argenx SE
SWB:1AE
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
A
|
argenx SE
SWB:1AE
|
NL |
|
U
|
Universal Music Group NV
OTC:UMGNF
|
NL |
|
A
|
Adidas AG
SWB:ADS
|
DE |
|
A
|
ACS Actividades de Construccion y Servicios SA
XMUN:OCI1
|
ES |
|
RWS Holdings PLC
OTC:RWSPF
|
UK |
|
P
|
Pagegroup PLC
OTC:MPGPF
|
UK |
|
H
|
Hecla Mining Co
XBER:HCL
|
US |
|
Beijing Enterprises Water Group Ltd
HKEX:371
|
HK |
|
Old Mutual Ltd
F:2KS
|
ZA |
|
Kao Corp
OTC:KAOCF
|
JP |
|
Investor AB
F:IVSD
|
SE |
|
Regeneron Pharmaceuticals Inc
LSE:0R2M
|
US |
|
G
|
General Motors Co
LSE:0R0E
|
US |
|
S
|
Sanofi SA
XHAM:SNW
|
FR |
|
E
|
Entergy Corp
DUS:ETY
|
US |
|
Applovin Corp
F:6RV
|
US |
|
E
|
Elis SA
F:7EL
|
FR |
|
E
|
Expeditors International of Washington Inc
DUS:EW1
|
US |
|
Wynn Resorts Ltd
F:WYR
|
US |
|
W
|
WEX Inc
F:WL9
|
US |
|
C
|
Cardiff Oncology Inc
SWB:XE7C
|
US |
|
M
|
Marchex Inc
F:NHM
|
US |
|
H
|
Holcim AG
XBER:HLBN
|
CH |
|
S
|
Samsung Electronics Co Ltd
LSE:SMSN
|
KR |
Bankruptcy Probability
argenx SE's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
argenx SE Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| NL |
|
argenx SE
XBRU:ARGX
|
41.5B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
358.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
177.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
166.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
108B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
75B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
58.8B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
|
39.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
argenx SE's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, argenx SE has total debt of 36.3m USD. This includes both short-term (0 USD) and long-term (36.3m USD) debt.
You can find a full breakdown on its Balance Sheet.
